Redwire Pioneering Biopharma Production in Space by Successfully Bioprinting Live Human Heart Tissue and Delivering Second Batch of PIL-BOX Pharmaceutical Crystal Experiments

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that it has successfully 3D bioprinted the first live human heart tissue sample though its 3D BioFabrication Facility (BFF) onboard the International Space Station (ISS). The tissue sample returned to Earth along with the second batch of pharmaceutical crystal experiments from Redwire’s PIL-BOX platform. Redwire’s space biotech capabilitie